selective BACE1 protease inhibitor

oral PD demonstrated on A_ in model

from optimization of prior ligand

Bioorg. Med. Chem. Lett., May 1, 2020

Amgen, Thousand Oaks, CA

Chemical structure of the "Compound 15" BACE1 selective inhibitor

“Compound 15” is a BACE1 selective inhibitor with a fluoro-olefin replacement for an N-aryl amide without the liability of a potential aniline metabolite. The compound has good oral PK in…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: